Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Mario, Scalamogna"'
Autor:
Umberto Maggi, Enzo Andorno, Giorgio Rossi, Luciano De Carlis, Umberto Cillo, Fabrizio Bresadola, Vincenzo Mazzaferro, Andrea Risaliti, Paolo Bertoli, Dario Consonni, Francesco Barretta, Tullia De Feo, Mario Scalamogna
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46643 (2012)
This study is the largest Italian survey on liver retransplantations (RET). Data report on 167 adult patients who received 2 grafts, 16 who received 3 grafts, and one who received 4 grafts over a 11 yr period.There was no statistically significant di
Externí odkaz:
https://doaj.org/article/75a535ebd3b74ad59ecbaf539a5dc43a
Autor:
Vito Lampasona, Marina Scavini, Matthew J Everly, Mario Scalamogna, Antonio Secchi, Emanuele Bosi, Paul I. Terasaki, Ezio Bonifacio, Massimo Cardillo, Francesca Poli, Paola Maffi, Alessia Mercalli, Rita Nano, Alejandro Espadas de Arias, Valeria Sordi, Raffaella Melzi, Lorenzo Piemonti
Publikováno v:
Diabetes
Long-term clinical outcome of islet transplantation is hampered by the rejection and recurrence of autoimmunity. Accurate monitoring may allow for early detection and treatment of these potentially compromising immune events. Islet transplant outcome
Autor:
Carla Colombo, Alessandro Palleschi, A. Perazzoli, Luigi Santambrogio, Davide Tosi, Stefano Gatti, Jacopo Colombo, R. Dossi, Lorenzo Rosso, Franco Valenza, M. Pizzocri, Diana Costantini, Paolo Reggiani, Sara Froio, Luciano Gattinoni, V. Salice, M. Pappalettera, Stefano Ferrero, Silvia Coppola, Mario Scalamogna, Mario Nosotti, Giorgio Rossi
Publikováno v:
Transplantation Proceedings. 44:1826-1829
Ex vivo lung perfusion (EVLP) has been validated as a valuable technique to increase the pool of organs available for lung transplantation.After a preclinical experience, we obtained permission from the Ethics Committee of our institution to transpla
Autor:
Annalisa Innocente, Andrea Gianatti, E. Benazzi, Francesca Poli, Angela Nocco, Roberto Fiocchi, Nicoletta Cagni, Mario Scalamogna
Publikováno v:
Human Immunology. 72:1045-1048
The development of solid-phase assays for antibody detection has aided in the frequent detection of human leukocyte antigen (HLA) antibodies in nonalloimmunized males. Some scientists have reported that these HLA antibodies are produced to pathogens
Autor:
T. Dimonopoli, A. Aniasi, R. Torelli, F. Poli, L. Crespiatico, S.E. Haworth, Mario Scalamogna, M.C. Mocellin, M.T. Aurelio, M.B. Colombo, M. Serafini
Publikováno v:
Transplantation Proceedings. 43:981-984
The Italian Bone Marrow Donor Register is the institutional organization for management of unrelated hematopoietic stem cell donors. The law requires only a donor's clinical history, but not a psychosocial profile for registration. We have studied th
Autor:
S. Frison, R. Lopa, M. Marini, K. Karpasitou, S. Bresciani, Francesca Poli, Mario Scalamogna, E. Longhi, Francesca Truglio, Francesca Drago
Publikováno v:
Vox Sanguinis. 99:158-162
BACKGROUND: The antigens of the Colton blood group system, Co(a) and Co(b), are encoded by a single gene that produces the aquaporin-1 (AQP1) protein, a water channel-forming protein, and are characterized by a single nucleotide polymorphism (SNP). A
Publikováno v:
Liver Transplantation. 16:308-313
Although human leukocyte antigen (HLA) crossmatching is often thought to be unnecessary for liver transplants (LTs), we provide evidence that for retransplants, it is essential. Sera from 139 retransplant patients who had received livers from decease
Autor:
Aharon Lubetzky, Galia Bartfeld, Francesca Poli, Mario Scalamogna, Katerina Karpasitou, Loretta Crespiatico, Laura Spinardi, Martin Ellis, Francesca Drago, Gili Kenet, Vered Yahalom
Publikováno v:
Transfusion Medicine and Hemotherapy. 37:III-VIII
Autor:
Patrizia Burra, Maria Guido, Simone Elizabeth Haworth, Alejandro Espadas de Arias, Ernesto Minola, Rosanna Torelli, Patrizia Boccagni, Massimo Cardillo, Giovambattista Pinzello, Francesca Poli, Mario Scalamogna, Marcello Vangeli, Luca S. Belli, Tullia Maria De Feo
Publikováno v:
Liver Transplantation. 15:390-399
In 20% to 30% of infected individuals, hepatitis C virus (HCV) can cause cirrhosis and hepatocellular carcinoma, for which liver transplantation is the best treatment available. HCV re-infection is universal, and hepatitis disease recurrence occurs i
Publikováno v:
Tissue Antigens. 4:383-386